This is from clinical pharmacology for infliximab (aka remicade) (what doctors use to look up side effect profiles):
In general, the types and frequencies of adverse reactions observed were similar in infliximab-treated patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or Crohn's disease. Of 1129 patients who had at least 4 infliximab infusions for rheumatoid arthritis, 21% had nausea (vomiting also occurred), 18% had headache, 12% had diarrhea, 12% had abdominal pain, 12% had cough, 10% had dyspepsia, 9% had fatigue, 8% had arthralgia, and 8% had back pain. A higher proportion of adverse reactions has been reported in rheumatoid arthritis patients receiving 10 mg/kg than 3 mg/kg; however, no differences in adverse events have been noted in Crohn's disease patients receiving a 5 or 10 mg/kg/dose. Post-marketing reports of interstitial lung disease including pulmonary fibrosis, interstitial pneumonitis, and very rare rapidly progressive disease have been received.
Crohn's Colitis diagnosed 6/08
Organic SCD since 4/09
Remicade since 6/09
Boswellia + Natren's Healthy Trinity probiotic + Cinnamon + Wild Oregano Oil + vitamin D + zinc + Barlean's fish oil